Attend the ATCC Vendor Showcase

Register here >>

Date: Sunday, December 15, 1:45 PM - 3:45 PM

Location: The New Orleans Ernest N. Morial Convention Center, Meeting Room D-1

Register today, limited seating is available. Light refreshments will be served.

hTERT-Immortalized Cells — Unique tools for tissue-relevant research

Speaker: Chengkang Zhang, Ph.D., Senior Scientist

ATCC Human telomerase (hTERT) immortalized cell lines combine the in vivo nature of primary cells and the long culture life of continuous cell lines. This section will provide an overview of the hTERT-immortalized cell line collection, and will examine the use of RPTEC/TERT1 (ATCC® No. CRL-4031™) and TIME (ATCC® No. CRL-4025™) cell lines to demonstrate how hTERT-immortalized cell lines can help you reach your research goals.

Induced Pluripotent and Mesenchymal Stem Cells — Cells with a lot of potential

Speaker: Chengkang Zhang, Ph.D., Senior Scientist

ATCC has a wide selection of induced pluripotent and mesenchymal stem cells along with an array of associated culture media and reagents. This section will provide an overview of the ATCC stem cell collection and describe how these resources can be used in cell biology studies.

TransfeX — Superior gene expression for hard-to-transfect cell types

Speaker: Kevin Grady, Product Line Manager

ATCC offers a superior lipid-based transfection reagent (TransfeX) that can be used to transfect difficult cell types, like primary and stem cells, and uncomplicated continuous cell lines. In this section, we will show how TransfeX provides higher transfection efficiency and lower cytotoxicity than other commercially available transfection reagents. We will also describe the HEKPlus Expression System for protein expression.

ATCC Molecular Signature Panels — Powerful tools for the genomics age

Speaker: Fang Tian, Ph.D., Lead Scientist

ATCC molecular signature panels focus on key components of cell signaling pathways such as EGFR, AKT, PI3K, PTEN, or p53. This section will describe how we generated these panels using authenticated cell lines containing critical gene copy number changes and site mutations, as well as how each panel was experimentally validated for genetic alterations, protein expression, and cell functionality.

CK ZhangChengkang Zhang, Ph.D.

Senior Scientist, ATCC Cell Systems

Bio: Dr. Zhang has a strong interest in developing cell systems that exhibit relevant in vivo phenotype in culture, in a user-friendly format that will generate consistent and reproducible results for end-users. Dr. Zhang has extensive experience in human embryonic stem cells and induced pluripotent stem cells, lineage-specific differentiation of human pluripotent stem cells, cell immortalization, molecular biology and pharmacology. Dr. Zhang received his Ph.D. in Molecular Biology from the Chinese Academy of Sciences in Shanghai and completed his postdoctoral training at the University of California, Irvine.

Kevin Grady

Product Line Manager, ATCC Cell Systems

Bio: Kevin has extensive experience in the management and production of products used by the scientific community. As a Product Line Business Manager at ATCC, Kevin is responsible for overseeing the development and production of primary cells, stem cells, hTERT immortalized cells, media systems, and reagents for cell culture. Kevin performed his graduate work in Biology at the State University of New York in Buffalo.

Fang TianFang Tian, Ph.D.

ATCC Cell Biology Group Leader, Lead Scientist

Bio: As Lead Scientist and the head of the ATCC Cell Biology, Dr. Tian is responsible for overseeing the preparation, authentication, characterization, quality control and cryopreservation of over 3,400 accessioned animal cell lines and hybridomas in the Cell Biology General Collection. Dr. Tian has extensive experience in cell biology and molecular biology. Dr. Tian's team is developing cell lines, cell panels and cell derivatives focusing on molecular pathology, cell signaling pathway and genetic alternation. Dr. Tian was Research Fellow at the Massachusetts General Hospital, Harvard Medical School. She conducted postdoctoral research at the Hillman Cancer Institute, University of Pittsburgh Medical Center.

Register Now

Limited space available

Learn more at the ATCC poster

Title: Blood Cells and Vessels

Date of Presentation: Monday, December 16

Board Number: B1332

Time of Presentation: 1:30 PM - 3:00 PM

Place: Exhibit Halls B-D

Stop By Booth #1224 And Meet With Atcc Experts

Date: Monday December 16

9:30 AM - 1:00 PM, Chengkang (CK) Zhang, Ph.D.

1:00 PM - 5:00 PM, Fang Tian, Ph.D.